Bisphenol P induces ovarian dysfunction by directly targeting PTGS2 and disrupting steroid hormone synthesis

Dingmei Qin1, Zijian Ma1, Zhipeng Lin1

  • 1Anhui Province Key Laboratory of Embryo Development and Reproductive Regulation, Anhui Province Key Laboratory of Pollution Damage and Biological Control for Huaihe River Basin, Fuyang Normal University, Fuyang, Anhui 236037, China.

Insights

Bisphenol P (BPP) causes ovarian toxicity by targeting PTGS2 and disrupting steroid hormone synthesis. This study reveals a novel mechanism for BPP

Area of Science:

  • Environmental Toxicology
  • Reproductive Toxicology
  • Molecular Toxicology

Background:

  • Structural analogues of Bisphenol A (BPA), like Bisphenol P (BPP), are suspected reproductive toxicants.
  • The specific ovarian toxicity of BPP remains largely uncharacterized.
  • Understanding BPP's impact is crucial due to its increasing use as a BPA substitute.

Purpose of the Study:

  • To elucidate the mechanisms underlying BPP-induced ovarian injury in peripubertal female mice.
  • To investigate BPP's effects on ovarian structure, function, and molecular pathways.
  • To identify key molecular targets and pathways affected by BPP exposure.

Main Methods:

  • In vivo mouse models (peripubertal females) with 8-week BPP exposure.
  • Integrated network toxicology and transcriptomics analysis.
  • Molecular docking, microscale thermophoresis (MST), and surface plasmon resonance (SPR) for interaction validation.
  • Analysis of ovarian morphology, DNA damage, apoptosis, and serum hormone levels (estradiol, LH).

Main Results:

  • BPP exposure induced significant ovarian injury, including follicular atresia, granulosa cell disorganization, DNA damage, and apoptosis.
  • Serum hormone analysis showed decreased estradiol and increased luteinizing hormone.
  • Prostaglandin-endoperoxide synthase 2 (PTGS2) was identified as a direct BPP target, with confirmed binding via molecular docking and biophysical methods (MST, SPR).
  • BPP suppressed the steroidogenic pathway by downregulating key genes (Lhcgr, Fshr, Nr5a1, Foxl2, Star, Cyp11a1, Hsd3b, Cyp19a1).

Conclusions:

  • Bisphenol P (BPP) is a potent ovarian toxicant.
  • BPP directly targets PTGS2, leading to a comprehensive transcriptional blockade of steroid hormone synthesis.
  • This study establishes a novel mechanism for BPP-induced ovarian toxicity and an assessment framework for emerging environmental contaminants.

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.3K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.3K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
654